A new medication has proved successful at treating multiple sclerosis (MS) during initial trials.
Research conducted at the University of Baltimore demonstrated that the cancer medication cyclophosphamide cut the level of disability in MS patients in addition to improving their physical functioning.
Nine patients used the medication for two years as part of the study and experienced an average 40 per cent reduction in disability and an 87 per cent improvement in tests measuring physical and mental function.
A decrease in the number of brain lesions suffered by the patients was also recorded, with the average amount falling from 6.5 to 1.2.
Dr Douglas Kerr, who led the study, notes that the drug is effective as it aims to reset the immune system back to a "naïve state" rather than keep the condition at bay.
In related news, the MS Society recently launched a new campaign to advertise its Carers' Emergency card which gives carers 24 hour access to temporary cover if they are called way for an emergency.
Please click here for advice about how to find a nursing care home.